Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page history shows a new site revision (v3.5.2) and removal of the previous revision (v3.5.0).SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a Study Status section to the Record History page and updated to Revision: v3.4.3 (2026-03-09). The previous revision v3.4.2 (2025-12-26) was deleted.SummaryDifference0.3%

- Check69 days agoChange DetectedThe page history shows Revision: v3.4.2 added and Revision: v3.4.1 removed, indicating a minor update to the history entries rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.1 has been added to the history, and the notices about funding lapse and Revision: v3.4.0 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedA site-wide notice about a lapse in government funding was added, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.